Uncategorized

Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape

Published

2 weeks ago

on

Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 billion the year prior. Here’s where all that cash went at companies like Johnson & Johnson, Amgen and Pfizer.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version